VVOS

Vivos Therapeutics Inc

0.4532

Jul 02 • 04:00PM ET -0.0451 (-9.05%)

Healthcare Medical Devices USA Nano NASD

Peers: MYO LFWD NUWE NVNO VTAK ICCM TNON NXL AMIX IRIX

| Held by: VTI VXF

Scroll to Statements

Index	-
Market Cap	6.30M
Enterprise Value	16.33M
Income	-24.99M
Sales	19.57M
Book/sh	-0.08
Cash/sh	0.15
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	268
IPO	Dec 11, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	0.32
P/B	-
P/C	2.99
P/FCF	-
EV/EBITDA	-
EV/Sales	0.83
Quick Ratio	0.27
Current Ratio	0.27
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-2.31
EPS next Y	-0.84
EPS next Q	-0.37
EPS this Y	32.13%
EPS next Y	40.21%
EPS next 5Y	-
EPS past 3/5Y	56.99% 39.15%
Sales past 3/5Y	2.87% 5.95%
EPS Y/Y TTM	-20.22%
Sales Y/Y TTM	33.77%
EPS Q/Q	-16.75%
Sales Q/Q	70.46%
Earnings	May 20 AMC
EPS/Sales Surpr.	-14.71% 18.22%

Insider Own	26.22%
Insider Trans	59.08%
Inst Own	13.12%
Inst Trans	13.16%
ROA	-137.59%
ROE	-1528.85%
ROIC	-824.45%
Gross Margin	53.70%
Oper. Margin	-115.47%
Profit Margin	-127.70%
SMA20	-18.89%
SMA50	-30.63%
SMA200	-73.53%
Trades

Shs Outstand	13.49M
Shs Float	10.25M
Short Float	9.24%
Short Ratio	0.55
Short Interest	0.95M
52W High	7.95 -94.30%
52W Low	0.38 18.33%
Volatility	15.90% 20.19%
ATR (14)	0.09
RSI (14)	39.15
Beta	6.16
Rel Volume	0.23
Avg Volume	1.73M
Volume	396,867

Perf Week	4.42%
Perf Month	-33.18%
Perf Quarter	-65.14%
Perf Half Y	-78.00%
Perf YTD	-77.67%
Perf Year	-88.17%
Perf 3Y	-96.45%
Perf 5Y	-99.60%
Perf 10Y	-
Recom	1.67
Target Price	2.45
Prev Close	0.50
Price	0.45
Change	-9.05%

Jun-30-26 08:45AM	Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants (GlobeNewswire) -7.81%
Jun-22-26 08:30AM	Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity (GlobeNewswire) -19.56%
Jun-11-26 08:30AM	Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering (GlobeNewswire)
Jun-10-26 09:03AM	Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients (GlobeNewswire) -8.75%
Jun-08-26 01:39PM	Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 (GlobeNewswire)
08:45AM	Loading…
Jun-05-26 08:45AM	Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing (GlobeNewswire) +24.84%
May-28-26 09:02PM	Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts (GuruFocus.com)
May-20-26 04:10PM	Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update (GlobeNewswire)
Apr-16-26 03:01AM	Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... (GuruFocus.com) -25.85%
Apr-15-26 04:20PM	Vivos Therapeutics Reports Full Year 2025 Financial Results (GlobeNewswire) +8.89%
08:45AM	Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call (GlobeNewswire)
08:30AM	Vivos Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby)
Apr-07-26 08:45AM	Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners (GlobeNewswire) -5.34%
Mar-26-26 08:45AM	Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market (GlobeNewswire)
Mar-17-26 08:45AM	Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy (GlobeNewswire)
05:15PM	Loading…
Mar-03-26 05:15PM	Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates (Zacks) +6.67%
Feb-05-26 08:45AM	Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies (GlobeNewswire)
Jan-20-26 05:31PM	Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds (GlobeNewswire) -7.11%
Jan-16-26 08:00AM	Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds (GlobeNewswire)
Jan-05-26 12:00PM	Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-16-25 08:45AM	Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan (GlobeNewswire)
Dec-15-25 05:30PM	Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST (GlobeNewswire)
Nov-26-25 08:01PM	Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... (GuruFocus.com)
Nov-19-25 04:20PM	Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 (GlobeNewswire) -10.17%
08:30AM	Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call (GlobeNewswire)
Nov-10-25 07:05AM	ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-06-25 08:05AM	Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 08:10AM	Zoetis (ZTS) Surpasses Q3 Earnings Estimates (Zacks)
Sep-30-25 08:30AM	Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device (GlobeNewswire)
Sep-17-25 08:30AM	Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment (GlobeNewswire)
03:06AM	Loading…
Aug-20-25 03:06AM	Vivos Therapeutics Inc (VVOS) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Aug-19-25 04:20PM	Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire)
08:30AM	Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call (GlobeNewswire)
Aug-12-25 05:15PM	Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-07-25 08:03AM	Vivos Calls Out Medical Blind Spot: OSA's Overlooked Dangerous Symptoms (PR Newswire)
Jul-30-25 08:45AM	Vivos Therapeutics Adds to Management Team to Support Expansion and Growth (GlobeNewswire)
08:10AM	Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-22-25 08:42AM	Ignored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health (PR Newswire)
Jul-10-25 08:02AM	CPAP Is Failing Patients With OCD--Vivos Exposes the Hidden Mental Health Risk (PR Newswire) +11.17%
Jul-01-25 08:30AM	Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance (GlobeNewswire) +22.47%
Jun-26-25 08:30AM	New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children (GlobeNewswire) +10.49%
Jun-11-25 08:30AM	Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada (GlobeNewswire) +5.21%
May-16-25 01:00PM	Vivos Therapeutics Inc (VVOS) Q1 2025 Earnings Call Highlights: Strategic Acquisitions and FDA ... (GuruFocus.com) -16.99%
May-15-25 06:00PM	Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire)
May-14-25 09:15AM	Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call (GlobeNewswire)
May-08-25 06:25PM	Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +5.63%
May-06-25 10:00AM	Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Apr-16-25 08:30AM	Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada (GlobeNewswire) -5.02%
Apr-02-25 09:01PM	Vivos Therapeutics Inc (VVOS) Q4 2024 Earnings Call Highlights: Strategic Shifts Propel Revenue ... (GuruFocus.com)
Apr-01-25 12:18AM	Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript (Seeking Alpha) -7.72%
Mar-31-25 06:55PM	Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -8.36%
04:20PM	Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Mar-28-25 08:30AM	Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call (GlobeNewswire)
Mar-26-25 05:15PM	Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates (Zacks) -8.31%
Mar-20-25 05:15PM	VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Feb-24-25 08:30AM	Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide (GlobeNewswire) +10.90%
Feb-18-25 08:30AM	Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. (GlobeNewswire) -11.50%
Dec-23-24 08:00AM	Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
Dec-18-24 12:00PM	All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy (Zacks) -7.35%
Nov-15-24 04:00AM	Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com) -8.97%
Nov-14-24 04:05PM	Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-13-24 05:00PM	Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Oct-08-24 07:30AM	Vivos Therapeutics Granted CPT Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association (GlobeNewswire)
Sep-19-24 07:00AM	Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -22.03%
Sep-18-24 10:05AM	Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children (Benzinga) +47.50%
07:00AM	Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring (GlobeNewswire)
Aug-14-24 04:05PM	Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire) -5.11%
07:30AM	Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Jul-01-24 12:33PM	Vivos eyes human trials for radiation treatment gel with IDE submission (Clinical Trials Arena) +6.31%
Jun-27-24 07:30AM	Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model (GlobeNewswire) +9.63%
Jun-12-24 07:30AM	Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance (GlobeNewswire) -8.24%
May-20-24 01:04PM	Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote FOR Re-Election of Its Highly Qualified Directors (GlobeNewswire)
May-15-24 01:01PM	Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -12.45%
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-14-24 04:05PM	Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire) +23.88%
07:30AM	Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Apr-09-24 02:45PM	Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices (News Direct) -9.08%
08:53AM	Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today? (InvestorPlace)
07:30AM	Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement (GlobeNewswire)
Apr-01-24 12:53PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.23%
Mar-28-24 08:53PM	VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
07:30AM	Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call (GlobeNewswire)
Feb-22-24 12:39PM	3 Stocks to Turn $1,000 Into $1 Million: February 2024 (InvestorPlace)
Feb-15-24 08:00AM	Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds (GlobeNewswire) +6.14%
Feb-12-24 09:24AM	Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions (News Direct)
Feb-06-24 07:30AM	Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities (GlobeNewswire)
Jan-08-24 07:30AM	Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA (GlobeNewswire)
Dec-11-23 07:30AM	Vivos Therapeutics Presents Groundbreaking Event: Empowering Women to Champion Airway (GlobeNewswire) -14.44%
Nov-30-23 08:51AM	Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today? (InvestorPlace) -40.24%
01:20AM	Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea (MedTech Dive)
Nov-29-23 01:04PM	Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea (News Direct) +833.94%
11:56AM	Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today? (InvestorPlace)
08:07AM	UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea (Reuters)
07:39AM	US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea (Reuters)
07:30AM	Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea (GlobeNewswire)
Nov-14-23 04:05PM	Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +9.71%
Nov-09-23 04:30PM	Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call (GlobeNewswire) -11.55% -5.84%
Nov-03-23 01:51PM	Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare (News Direct) -5.52%

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.

Co-FounderMr. R. Kirk Huntsman

CFOMr. Bradford K. Amman

Co-Founder & Senior VP of Product and TechnologyMr. Todd Huntsman

Co-Founder and Senior VP of Events & Clinical Advisory ServicesMs. RaeAnn Byrnes

Co-Founder & Executive VP of OperationsMs. Susan McCullough

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Skaff Michael C	10% Owner	Mar 31 '26	Buy	1.34	1,353,625	1,813,858	1,353,625	Apr 02 07:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

VVOS

Vivos Therapeutics Inc

Upgrade your Finviz experience